American Home, Warner-Lambert Set $72 Billion Merger Deal

 

Now that American Home Products (AHP) and Warner-Lambert (WLA) have agreed to a $72 billion merger, the questions remains: Can they pull it off?

The merger will create a company -- to be named AmericanWarner -- with pro forma sales of $26 billion and a $3 billion research-and-development budget. The R&D budget would be one of the industry's largest, which is crucial for companies trying to keep earnings growing even as they invest heavily on complex drugs to treat maladies such as cancer and AIDS.

Warner-Lambert Merger: Join the discussion onTSC Message Boards.

Any skepticism over the deal, which was announced early Thursday morning after reports broke Wednesday, stems from American Home's failure over the last two years to close a pair of widely discussed deals.

"American Home's track record in this area is suspect," said Tom Burnett, the president of institutional researcher Merger Insight, referring to American Home's failure to close 1998 deals with SmithKline Beecham (SBH) and Monsanto (MTC). "They'd better be focused this time."

If investors are worried about the prospect of the deal falling apart, they weren't letting on. Warner-Lambert and American Home shares were higher Thursday morning after the stocks of both companies rallied sharply Wednesday on reports of the deal. [American Home ended down 1 at 55 while Warner-Lambert closed up 6 5/16 to 90 1/8.]

Hemant Shah, an independent analyst, sees much potential for an amicable union. If the deal dies, though, Shah predicts it will be because of American Home's $3.75 billion settlement with plaintiffs over the firm's diet drugs.

"That's the one thing that could scuttle it," said Shah, who rates Warner-Lambert buy and American Home neutral.

American Home executives scoff at the suggestion that the diet drug settlement will kill the merger. They say the deal should be completed by mid-2000.

"From the company's perspective, that issue has been dealt with and set aside," says American Home spokesman Doug Petkus. "The companies can deal with this together."

Burnett said he was leaning toward agreeing with American Home's viewpoint, saying Warner-Lambert's management has a reputation for being stable and that it wouldn't enter an agreement without careful consideration.

"Doesn't Warner-Lambert know about [the settlement]?" Burnett asked. "I mean, they're not coming into it blindly, and the whole timing was critical because they waited until there was a settlement." At the same time, Burnett added that if the fen-phen agreement fell apart, there could be severe ramifications.

Analysts say that they don't anticipate that management ego clashes will destroy the deal, as they reportedly did with American Home's talks with SmithKline in January 1998, if only because there appears to be some executive symmetry.

John R. Stafford, American Home's chairman, president and chief executive, is known as a strong-willed leader. Stafford will become chairman for 18 months before retiring, according to a joint press release from the companies. Lodewijk de Vink, Warner-Lambert's chairman, president and chief executive, who has a more diplomatic reputation, would then take over upon Stafford's retirement.

Both Shah and Burnett said the merger could set off a stream of agreements from competitors looking to keep up. At the same time, both analysts said the American Home-Warner Lambert deal simply takes its place in line with a decade's worth of deals that is likely to continue. Shah said investors should expect further consolidation in the industry. "There's a lot of discussions going on," Burnett said.

>To order reprints of this article, click here: Reprints

TheStreet Premium Services    For Personal Service: 877-471-2967

Jim Cramer
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
New: ETF Profits
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Doug Kass
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
Dow Jones S&P 500 NASDAQ 10-Year Note
12,890.46 1,351.95 2,927.23 20.47
Oil *
118.75
UP
6.51
UP
1.99
UP
11.37
UP
0.72
10 Yr
2.05%
SPDR Gold
168.02
+0.05%
+0.15%
+0.39%
+3.65%
Data delayed 20 minutes

Top Stories and Tools

Brokerage Partners

After the Bell

Before the Bell

Booyah! Newsletter

ETF Daily

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy.
Podcasts

Connect with TheStreet